Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1990 Apr;43(4):287–290. doi: 10.1136/jcp.43.4.287

Histogenesis of ovarian malignant mixed mesodermal tumours.

T J Clarke 1
PMCID: PMC502355  PMID: 2160478

Abstract

The histogenesis of ovarian malignant mixed mesodermal tumours, which includes the concept of metaplastic carcinoma, is controversial. Four such tumours were examined for evidence of metaplastic transition from carcinoma to sarcoma using morphology and reticulin stains. Consecutive sections were stained immunohistochemically using cytokeratin and vimentin to determine whether cells at the interface between carcinoma and sarcoma expressed both cytokeratin and vimentin. There was no evidence of morphological, architectural, or immunohistochemical transitions from carcinoma to sarcoma in the four tumours studied. This suggests that ovarian malignant mixed mesodermal tumours are not metaplastic carcinomas but are composed of histogenetically different elements.

Full text

PDF
287

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addis B. J., Corrin B. Pulmonary blastoma, carcinosarcoma and spindle-cell carcinoma: an immunohistochemical study of keratin intermediate filaments. J Pathol. 1985 Dec;147(4):291–301. doi: 10.1002/path.1711470407. [DOI] [PubMed] [Google Scholar]
  2. Azoury R. S., Woodruff J. D. Primary ovarian sarcomas. Report of 43 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol. 1971 Jun;37(6):920–941. [PubMed] [Google Scholar]
  3. Barwick K. W., LiVolsi V. A. Malignant mixed mesodermal tumors of the ovary: a clinicopathologic assessment of 12 cases. Am J Surg Pathol. 1980 Feb;4(1):37–42. [PubMed] [Google Scholar]
  4. Ben-Ze'ev A. Differential control of cytokeratins and vimentin synthesis by cell-cell contact and cell spreading in cultured epithelial cells. J Cell Biol. 1984 Oct;99(4 Pt 1):1424–1433. doi: 10.1083/jcb.99.4.1424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bonazzi del Poggetto C., Virtanen I., Lehto V. P., Wahlström T., Saksela E. Expression of intermediate filaments in ovarian and uterine tumors. Int J Gynecol Pathol. 1983;1(4):359–366. doi: 10.1097/00004347-198301040-00006. [DOI] [PubMed] [Google Scholar]
  6. Centola G. M. Long-term in vitro growth of a heterologous mixed Müllerian tumor of the ovary. Invasion Metastasis. 1986;6(2):123–132. [PubMed] [Google Scholar]
  7. Clarke T. J. Sarcoma-like mural nodules in cystic serous ovarian tumours. J Clin Pathol. 1987 Dec;40(12):1443–1448. doi: 10.1136/jcp.40.12.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cooper P. Mixed mesodermal tumor and clear cell carcinoma arising in ovarian endometriosis. Cancer. 1978 Dec;42(6):2827–2831. doi: 10.1002/1097-0142(197812)42:6<2827::aid-cncr2820420643>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  9. Czernobilsky B., LaBarre G. C. Carcinosarcoma and mixed mesodermal tumor of the ovary. A clinicopathologic analysis of 9 cases. Obstet Gynecol. 1968 Jan;31(1):21–32. doi: 10.1097/00006250-196801000-00004. [DOI] [PubMed] [Google Scholar]
  10. Dehner L. P., Norris H. J., Taylor H. B. Carcinosarcomas and mixed mesodermal tumors of the ovary. Cancer. 1971 Jan;27(1):207–216. doi: 10.1002/1097-0142(197101)27:1<207::aid-cncr2820270129>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  11. Dervan P. A. Alpha-1-antitrypsin hematoxylin and eosin fluorescence: a rapid, useful screening technic. Am J Clin Pathol. 1984 Aug;82(2):188–190. doi: 10.1093/ajcp/82.2.188. [DOI] [PubMed] [Google Scholar]
  12. Dictor M. Alpha-1-antitrypsin in a malignant mixed mesodermal tumor of the ovary. Am J Surg Pathol. 1981 Sep;5(6):543–550. doi: 10.1097/00000478-198109000-00003. [DOI] [PubMed] [Google Scholar]
  13. Dictor M. Malignant mixed mesodermal tumor of the ovary: a report of 22 cases. Obstet Gynecol. 1985 May;65(5):720–724. [PubMed] [Google Scholar]
  14. Dictor M. Ovarian malignant mixed mesodermal tumor: the occurrence of hyaline droplets containing alpha 1-antitrypsin. Hum Pathol. 1982 Oct;13(10):930–933. doi: 10.1016/s0046-8177(82)80055-5. [DOI] [PubMed] [Google Scholar]
  15. Fenn M. E., Abell M. R. Carcinosarcoma of the ovary. Am J Obstet Gynecol. 1971 Aug 15;110(8):1066–1074. doi: 10.1016/0002-9378(71)90304-8. [DOI] [PubMed] [Google Scholar]
  16. Fromowitz F. B., Bard R. H., Koss L. G. The epithelial origin of a malignant mesodermal mixed tumor of the bladder: report of a case with long-term survival. J Urol. 1984 Nov;132(5):978–981. doi: 10.1016/s0022-5347(17)49976-9. [DOI] [PubMed] [Google Scholar]
  17. Geisinger K. R., Dabbs D. J., Marshall R. B. Malignant mixed müllerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations. Cancer. 1987 May 15;59(10):1781–1790. doi: 10.1002/1097-0142(19870515)59:10<1781::aid-cncr2820591017>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  18. Hanjani P., Petersen R. O., Lipton S. E., Nolte S. A. Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: report of eight cases and review of literature. Obstet Gynecol Surv. 1983 Sep;38(9):537–545. doi: 10.1097/00006254-198309000-00002. [DOI] [PubMed] [Google Scholar]
  19. Huszar M., Herczeg E., Lieberman Y., Geiger B. Distinctive immunofluorescent labeling of epithelial and mesenchymal elements of carcinosarcoma with antibodies specific for different intermediate filaments. Hum Pathol. 1984 Jun;15(6):532–538. doi: 10.1016/s0046-8177(84)80006-4. [DOI] [PubMed] [Google Scholar]
  20. Lane E. B., Hogan B. L., Kurkinen M., Garrels J. I. Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature. 1983 Jun 23;303(5919):701–704. doi: 10.1038/303701a0. [DOI] [PubMed] [Google Scholar]
  21. Marchevsky A. M., Kaneko M. Bilateral ovarian endometriosis associated with carcinosarcoma of the right ovary and endometrioid carcinoma of the left ovary. Am J Clin Pathol. 1978 Oct;70(4):709–712. doi: 10.1093/ajcp/70.4.709. [DOI] [PubMed] [Google Scholar]
  22. Masuda A., Takeda A., Fukami H., Yamada C., Matsuyama M. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells. Cancer. 1987 Dec 1;60(11):2696–2703. doi: 10.1002/1097-0142(19871201)60:11<2696::aid-cncr2820601120>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  23. Oberman H. A. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol. 1987 Dec;11(12):918–929. doi: 10.1097/00000478-198712000-00002. [DOI] [PubMed] [Google Scholar]
  24. Ricci M., Santini D., Mazzoleni G., Gelli M. C., Bazzocchi F. Malignant mixed mesodermal tumors of the ovary. A clinico-pathological study of four new cases. Arch Anat Cytol Pathol. 1987;35(1):41–43. [PubMed] [Google Scholar]
  25. Saunders P., Price A. B., Taylor R. W. Mixed mesodermal tumour of the ovary arising in pelvic endometriosis. Proc R Soc Med. 1970 Oct;63(10):1050–1051. [PMC free article] [PubMed] [Google Scholar]
  26. Takeda A., Matsuyama M., Kuzuya K., Chihara T., Tsubouchi S., Takeuchi S. Mixed mesodermal tumor of the ovary with carcinoembryonic antigen and alkaline phosphatase production. Histochemical, autoradiographic, and electron microscopic studies of heterotransplanted tumors in athymic nude mice. Cancer. 1984 Jan 1;53(1):103–112. doi: 10.1002/1097-0142(19840101)53:1<103::aid-cncr2820530119>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  27. Weidner N., Zekan P. Carcinosarcoma of the colon. Report of a unique case with light and immunohistochemical studies. Cancer. 1986 Sep 1;58(5):1126–1130. doi: 10.1002/1097-0142(19860901)58:5<1126::aid-cncr2820580525>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  28. Young R. H. Carcinosarcoma of the urinary bladder. Cancer. 1987 Apr 1;59(7):1333–1339. doi: 10.1002/1097-0142(19870401)59:7<1333::aid-cncr2820590717>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES